---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-003312"
form_type: "8-K"
ticker: "OSUR"
cik: "0001116463"
company_name: "ORASURE TECHNOLOGIES INC"
filed_at: "2021-11-08T23:59:59+00:00"
generated_at: "2026-06-28T11:16:00.523715+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# OraSure appoints Nancy Gagliano and Anne Whitaker to board of directors

## Summary
- Board increased from nine to ten members; appointments effective November 8, 2021.
- Dr. Gagliano brings experience from NIH RADx program and CVS Health; will serve on Nominating & Corp Governance Committee.
- Ms. Whitaker brings pharma executive and public board experience; will serve on Audit Committee.
- Each received initial equity award of $105,000 in restricted shares vesting over two years.
- Both directors are independent under Nasdaq listing rules.

## SEC filing metadata
- accession: 0000950170-21-003312
- form_type: 8-K
- ticker: OSUR
- cik: 0001116463
- company_name: ORASURE TECHNOLOGIES INC
- filed_at: 2021-11-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1116463/000095017021003312/0000950170-21-003312-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1116463/000095017021003312/osur-20211107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-003312
- JSON: https://secwatch.observer/filing/0000950170-21-003312.json
- Plain text: https://secwatch.observer/filing/0000950170-21-003312.txt

## Key facts
- Executive change
  Nancy J. Gagliano was appointed as Director at ORASURE TECHNOLOGIES INC.
  - Action: appointed
  - Role: Director
  source text: the Board appointed Nancy J. Gagliano, M.D. and Anne C. Whitaker as new members of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1116463/000095017021003312/0000950170-21-003312-index.htm
- Executive change
  Anne C. Whitaker was appointed as Director at ORASURE TECHNOLOGIES INC.
  - Action: appointed
  - Role: Director
  source text: the Board appointed Nancy J. Gagliano, M.D. and Anne C. Whitaker as new members of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1116463/000095017021003312/0000950170-21-003312-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.